Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Category Archives: Processa Pharmaceuticals Inc. PCSA

MissionIRNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Featured in Korea Biomedical Review Article

Posted on November 24, 2020 by MissionIR

Processa Pharmaceuticals (NASDAQ: PCSA), a clinical-stage biopharmaceutical company developing products to improve the survival and/or quality of life for patients who have unmet medical needs, was featured in a recent article published in the Korea Biomedical Review. The piece, titled … Continue reading →

Posted in Processa Pharmaceuticals Inc. PCSA | Leave a comment

MissionIRNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Announces Participation Schedule for Upcoming Investor Conferences

Posted on November 16, 2020 by MissionIR

Processa Pharmaceuticals (NASDAQ: PCSA), a clinical-stage biopharmaceutical company developing products to improve the survival and/or quality of life for patients who have unmet medical needs, today announced that management will participate in two upcoming investor conferences. According to the update, … Continue reading →

Posted in MissionIRNewsBreaks, Processa Pharmaceuticals Inc. PCSA | Leave a comment

MissionIRNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Announces Q3 2020 Results, Provides Corporate Update

Posted on November 13, 2020 by MissionIR

Processa Pharmaceuticals (NASDAQ: PCSA), a clinical-stage biopharmaceutical company focused on the development of drug products intended to provide treatment for and improve the survival and/or quality of life for patients with unmet medical needs or no alternative treatment, on Thursday … Continue reading →

Posted in MissionIRNewsBreaks, Processa Pharmaceuticals Inc. PCSA | Leave a comment

MissionIRNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Announces Board Appointment of Dr. Khalid Islam

Posted on November 5, 2020 by MissionIR

Processa Pharmaceuticals (NASDAQ: PCSA), a clinical-stage biopharmaceutical company developing products to improve survival and/or quality of life for patients with a high unmet medical need, today announced the appointment of Dr. Khalid Islam to its board of directors. Dr. Islam … Continue reading →

Posted in MissionIRNewsBreaks, Processa Pharmaceuticals Inc. PCSA | Leave a comment

MissionIRNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Featured in Research Report

Posted on November 4, 2020 by MissionIR

Processa Pharmaceuticals (NASDAQ: PCSA), a clinical-stage biopharmaceutical company developing products to improve survival and/or quality of life for patients with high unmet medical need conditions, was featured in an institutional research report by Craig-Hallum Capital Group LLC. The report discusses … Continue reading →

Posted in MissionIRNewsBreaks, Processa Pharmaceuticals Inc. PCSA | Leave a comment

MissionIRNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) to Host Call, Live Webcast to Discuss Q3 2020 Results, Clinical Pipeline

Posted on November 3, 2020 by MissionIR

Processa Pharmaceuticals (NASDAQ: PCSA), a clinical-stage biopharmaceutical company developing products to improve survival and/or quality of life for patients with high unmet medical need conditions, today announced that it will host a conference call and live webcast at 5:30 p.m. … Continue reading →

Posted in MissionIRNewsBreaks, Processa Pharmaceuticals Inc. PCSA | Leave a comment

MissionIRNewsBreaks – Why Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Is ‘One to Watch’

Posted on November 2, 2020 by MissionIR

Processa Pharmaceuticals (NASDAQ: PCSA) is a clinical-stage biopharmaceutical company focused on the development of drug products for patients with high unmet medical need conditions or no alternative treatment options. A recent article discussing the company reads, “Headquartered in Hanover, Maryland, … Continue reading →

Posted in Processa Pharmaceuticals Inc. PCSA | Leave a comment

MissionIRNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Appoints Serial Entrepreneur as New Chief Operating Officer

Posted on October 13, 2020 by MissionIR

Processa Pharmaceuticals (NASDAQ: PCSA), a clinical-stage biopharmaceutical company developing products to improve survival and/or quality of life for patients who have high unmet medical needs, has appointed a new chief operating officer. Michael Floyd, a serial entrepreneur who has formed … Continue reading →

Posted in MissionIRNewsBreaks, Processa Pharmaceuticals Inc. PCSA | Leave a comment

MissionIRNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Featured in Simply Wall St Article

Posted on October 9, 2020 by MissionIR

Processa Pharmaceuticals (NASDAQ: PCSA), a clinical-stage biopharmaceutical company focused on the development of drug products for patients with high unmet medical need conditions or no alternative treatment options, was featured in a Simply Wall St article. The piece highlights PCSA … Continue reading →

Posted in Processa Pharmaceuticals Inc. PCSA | Leave a comment

MissionIRNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Announces Closing of Public Offering

Posted on October 7, 2020 by MissionIR

Processa Pharmaceuticals (NASDAQ: PCSA) has closed its previously announced underwritten public offering of 4,800,000 shares of common stock, which were offered to the public for $4 per share. The clinical-stage biopharmaceutical company, which focuses on the development of drug products … Continue reading →

Posted in MissionIRNewsBreaks, Processa Pharmaceuticals Inc. PCSA | Leave a comment